Canopy Growth soars on reports the White House is considering reclassifying cannabis as a “Schedule III” drug. Here’s why CGC shares currently look attractive as a long-term holding.

Canopy Growth Corporation is rated Hold due to execution risks & uncertainty around US marijuana reclassification timing.

Canopy Growth has agreed to acquire Quebec-based craft cannabis company MTL Cannabis in a deal worth about 125 million Canadian dollars ($90.8 million). The Canadian cannabis company said Monday that ...

Canopy Growth (NASDAQ: CGC) stock soared 17% through 12:50 p.m. ET Friday on some positive marijuana news out of the White ...

Interior designers share why they love incorporating canopy beds into projects and also highlight other bedding trends for ...

A canopy bed can transform a room, creating a dramatic focal point. The best canopy beds are sturdy and visually stunning, and are a centerpiece for a room that lasts the test of time. They’re also ...